Processa Pharmaceuticals

Quarterly Financials

Values in thousands2025-12-312025-09-302025-06-302025-03-31
Revenue
$0
$0
$0
$0
Gross Profit
EBITDA
-3,753
-3,436
-3,950
-2,846
EBIT
-3,754
-3,436
-3,950
-2,846
Net Income
-3,358
-3,436
-3,933
-2,834
Net Change In Cash
0
0
0
0
Free Cash Flow
-5,630
-3,484
-2,270
-2,729
Cash
5,536
6,308
6,936
2,897
Basic Shares
2,571
1,901
622
381

Annual Financials

Values in thousands2025-12-312024-12-312023-12-312022-12-31
Revenue
$0
$0
$0
$0
Gross Profit
-1
-874
EBITDA
-13,987
-12,050
-11,456
-19,468
EBIT
-13,988
-12,051
-11,457
-20,257
Net Income
-13,563
-11,850
-11,121
-27,424
Net Change In Cash
0
0
0
0
Free Cash Flow
-11,385
-11,248
-8,066
-9,605
Cash
5,536
1,191
4,706
6,503
Basic Shares
1,309
122
52
32

Earnings Calls

QuarterEPS
2025-09-30
-$0.07
2025-06-30
-$0.25
2025-03-31
-$0.30
2024-12-31
-$0.74